Periprocedural outcome in patients undergoing left atrial appendage occlusion with the Watchman FLX device: The ITALIAN-FLX registry [PDF]
IntroductionThe Watchman FLX is a novel device for transcatheter left atrial appendage occlusion (LAAO) specifically designed to improve procedural performance in more complex anatomies with a better safety profile.
Francesco Tomassini, Sérgio Berti
exaly +4 more sources
Gender differences in outcomes after left atrial appendage closure with Watchman FLX device: insights from the Italian-FLX registry [PDF]
IntroductionRecent studies have shown gender differences in cardiovascular outcomes after left atrial appendage closure (LAAC), highlighting different complication rates and adverse events, particularly in short-term assessments.
Salvatore Sacca
exaly +4 more sources
Transition from WATCHMAN V.2.5 to WATCHMAN FLX for closure of the left atrial appendage: echocardiographic and clinical findings [PDF]
Introduction Interventional closure of the left atrial appendage (LAAC) has been established as an alternative treatment for patients with atrial fibrillation (AF) and an elevated risk of stroke.
Henning Ebelt +4 more
doaj +2 more sources
Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry [PDF]
Background: The Watchman FLX is a device upgrade of the Watchman 2.5 that incorporates several design enhancements intended to simplify left atrial appendage occlusion (LAAO) and improve procedural outcomes. This study compares peri-procedural results of
Ignacio Cruz-González +35 more
doaj +2 more sources
A Randomized Controlled Trial Comparing the TruSteer and FXD Double Curve Delivery Systems for Left Atrial Appendage Occlusion With the Watchman FLX Pro Device-The GUIDE-LAAO Study. [PDF]
ABSTRACT Background Deflectable delivery systems have been introduced to enhance coaxial alignment and procedural efficacy during left atrial appendage occlusion (LAAO), yet randomized comparisons with conventional fixed‐curve systems are lacking. Aims The GUIDE‐LAAO trial evaluated whether the TruSteer deflectable delivery system is non‐inferior to ...
Taieb P +3 more
europepmc +2 more sources
Recurrent device-related thrombosis after left atrial appendage closure with the watchman FLX: A case report and literature review [PDF]
Background: Left atrial appendage closure (LAAC) effectively lowers stroke risk in atrial-fibrillation (AF) patients who cannot tolerate long-term anticoagulation.
Yuemiao Jiao +3 more
doaj +2 more sources
Circumflex to Left Atrial Appendage Fistula Associated With Watchman FLX Closure Device [PDF]
An 82-year-old man who had undergone Watchman FLX (Boston Scientific) device implantation presented with dyspnea. Multimodality evaluation demonstrated a small fistula from the proximal circumflex artery to the left atrial appendage.
Stefan Milutinovic, MD +4 more
doaj +2 more sources
Racial and Ethnic Disparities in the Use and Outcomes With WATCHMAN FLX: A SURPASS Analysis of the NCDR Left Atrial Appendage Occlusion Registry [PDF]
Background Left atrial appendage occlusion (LAAO) is increasingly used as an alternative to oral anticoagulation for stroke prevention in select patients with atrial fibrillation.
Oluseun O. Alli +13 more
doaj +2 more sources
Intracardiac echocardiography guided simultaneous atrial fibrillation ablation and Micra implantation 14 days after Watchman FLX implantation [PDF]
Key Clinical Message Atrial fibrillation ablation, including pulmonary vein isolation immediately after left atrial appendage closure (LAAC), is a rare and challenging issue.
Ryuki Chatani +6 more
doaj +2 more sources
Conscious Sedation for WATCHMAN FLX Implantation Using Transesophageal Echocardiography Guidance [PDF]
Joseph C. Crowder, M.D. +2 more
doaj +2 more sources

